283 related articles for article (PubMed ID: 33010409)
1. Liver Stiffness by Magnetic Resonance Elastography Predicts Future Cirrhosis, Decompensation, and Death in NAFLD.
Gidener T; Ahmed OT; Larson JJ; Mara KC; Therneau TM; Venkatesh SK; Ehman RL; Yin M; Allen AM
Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1915-1924.e6. PubMed ID: 33010409
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance elastography for prediction of long-term progression and outcome in chronic liver disease: A retrospective study.
Gidener T; Yin M; Dierkhising RA; Allen AM; Ehman RL; Venkatesh SK
Hepatology; 2022 Feb; 75(2):379-390. PubMed ID: 34510513
[TBL] [Abstract][Full Text] [Related]
3. Change in serial liver stiffness measurement by magnetic resonance elastography and outcomes in NAFLD.
Gidener T; Dierkhising RA; Mara KC; Therneau TM; Venkatesh SK; Ehman RL; Yin M; Allen AM
Hepatology; 2023 Jan; 77(1):268-274. PubMed ID: 35642504
[TBL] [Abstract][Full Text] [Related]
4. MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study.
Han MAT; Vipani A; Noureddin N; Ramirez K; Gornbein J; Saouaf R; Baniesh N; Cummings-John O; Okubote T; Setiawan VW; Rotman Y; Loomba R; Alkhouri N; Noureddin M
Liver Int; 2020 Sep; 40(9):2242-2251. PubMed ID: 32652744
[TBL] [Abstract][Full Text] [Related]
5. Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants.
Ajmera V; Kim BK; Yang K; Majzoub AM; Nayfeh T; Tamaki N; Izumi N; Nakajima A; Idilman R; Gumussoy M; Oz DK; Erden A; Quach NE; Tu X; Zhang X; Noureddin M; Allen AM; Loomba R
Gastroenterology; 2022 Oct; 163(4):1079-1089.e5. PubMed ID: 35788349
[TBL] [Abstract][Full Text] [Related]
6. Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease.
Ajmera VH; Liu A; Singh S; Yachoa G; Ramey M; Bhargava M; Zamani A; Lopez S; Mangla N; Bettencourt R; Rizo E; Valasek M; Behling C; Richards L; Sirlin C; Loomba R
Hepatology; 2020 Mar; 71(3):849-860. PubMed ID: 31556124
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study.
Kim BK; Bergstrom J; Loomba R; Tamaki N; Izumi N; Nakajima A; Idilman R; Gumussoy M; Oz DK; Erden A; Truong E; Yang JD; Noureddin M; Allen AM; Loomba R; Ajmera V
Hepatology; 2023 Dec; 78(6):1858-1866. PubMed ID: 37203233
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of controlled attenuation parameter and liver stiffness measurement for detecting increased arterial stiffness in asymptomatic populations in China.
Yu XY; Song XX; Tong YL; Wu LY; Song ZY
Medicine (Baltimore); 2020 Nov; 99(48):e23360. PubMed ID: 33235107
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study.
Cardoso CRL; Villela-Nogueira CA; Leite NC; Salles GF
Cardiovasc Diabetol; 2021 Sep; 20(1):193. PubMed ID: 34560854
[TBL] [Abstract][Full Text] [Related]
10. Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease.
Petta S; Sebastiani G; Viganò M; Ampuero J; Wai-Sun Wong V; Boursier J; Berzigotti A; Bugianesi E; Fracanzani AL; Cammà C; Enea M; Grottes MD; Di Marco V; Younes R; Keyrouz A; Mazzola S; Mendoza Y; Pennisi G; Romero-Gomez M; Craxì A; de Ledinghen V
Clin Gastroenterol Hepatol; 2021 Apr; 19(4):806-815.e5. PubMed ID: 32621970
[TBL] [Abstract][Full Text] [Related]
11. Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non-alcoholic fatty liver disease.
Park JG; Jung J; Verma KK; Kang MK; Madamba E; Lopez S; Qas Yonan A; Liu A; Bettencourt R; Sirlin C; Loomba R
Aliment Pharmacol Ther; 2021 May; 53(9):1030-1037. PubMed ID: 33764550
[TBL] [Abstract][Full Text] [Related]
12. Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease.
Siddiqui MS; Vuppalanchi R; Van Natta ML; Hallinan E; Kowdley KV; Abdelmalek M; Neuschwander-Tetri BA; Loomba R; Dasarathy S; Brandman D; Doo E; Tonascia JA; Kleiner DE; Chalasani N; Sanyal AJ;
Clin Gastroenterol Hepatol; 2019 Jan; 17(1):156-163.e2. PubMed ID: 29705261
[TBL] [Abstract][Full Text] [Related]
13. Transient elastography can stratify patients with Child-Pugh A cirrhosis according to risk of early decompensation.
Dillon A; Galvin Z; Sultan AA; Harman D; Guha IN; Stewart S
Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1434-1440. PubMed ID: 30063481
[TBL] [Abstract][Full Text] [Related]
14. Liver stiffness can predict decompensation and need for beta-blockers in compensated cirrhosis: a step beyond Baveno-VI criteria.
Jindal A; Sharma S; Agarwal S; Kumar M; Saraya A; Sarin SK
Hepatol Int; 2022 Feb; 16(1):89-98. PubMed ID: 35072932
[TBL] [Abstract][Full Text] [Related]
15. Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial.
Harrison SA; Dennis A; Fiore MM; Kelly MD; Kelly CJ; Paredes AH; Whitehead JM; Neubauer S; Traber PG; Banerjee R
PLoS One; 2018; 13(9):e0203054. PubMed ID: 30192782
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance elastography (MRE) outperforms acoustic force radiation impulse (ARFI) in predicting oesophageal varices in obese NAFLD cirrhosis.
Roy A; Verma N; Jajodia S; Goenka U; Tiwari A; Sonthalia N; Goenka M
Abdom Radiol (NY); 2024 Apr; ():. PubMed ID: 38652124
[TBL] [Abstract][Full Text] [Related]
17. Compensated Advanced Chronic Liver Disease in Nonalcoholic Fatty Liver Disease: Two-Step Strategy is Better than Baveno Criteria.
Elhence A; Anand A; Biswas S; Vaishnav M; Yadav R; Das P; Panwar R; Agarwal S; Gamanagatti S; Kumar R; Shalimar
Dig Dis Sci; 2023 Mar; 68(3):1016-1025. PubMed ID: 35670897
[TBL] [Abstract][Full Text] [Related]
18. Baseline and serial liver stiffness measurement in prediction of portal hypertension progression for patients with compensated cirrhosis.
Wang JH; Chuah SK; Lu SN; Hung CH; Kuo CM; Tai WC; Chiou SS
Liver Int; 2014 Oct; 34(9):1340-8. PubMed ID: 24620731
[TBL] [Abstract][Full Text] [Related]
19. Influence of liver stiffness heterogeneity on staging fibrosis in patients with nonalcoholic fatty liver disease.
Kawamura N; Imajo K; Kalutkiewicz KJ; Nagai K; Iwaki M; Kobayashi T; Nogami A; Honda Y; Kessoku T; Ogawa Y; Higurashi T; Hosono K; Takahashi H; Yoneda M; Saito S; Aishima S; Toyoda H; Hayashi H; Sumida Y; Ehman RL; Nakajima A
Hepatology; 2022 Jul; 76(1):186-195. PubMed ID: 34951726
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
